We are live on
!
Find out more
FT
Fiduciary Trust Portfolio holdings
AUM
$8.46B
1-Year Est. Return
21.38%
This Fund
S&P 500
This Quarter
Est. Return
+14.58%
1 Year Est. Return
+21.38%
3 Year Est. Return
+65.44%
5 Year Est. Return
+79.3%
10 Year Est. Return
+269.63%
AUM
$4.8B
AUM Growth
+$554M
(+13%)
Cap. Flow
-$22.1M
Cap. Flow
% of AUM
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
39.37%
Holding
591
New
45
Increased
199
Reduced
234
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$7.99M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$7.92M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$7.79M |
| 4 |
Honeywell
HON
|
+$3.49M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$3.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$83.1M |
| 2 |
EV
Eaton Vance Corp.
EV
|
+$9.79M |
| 3 |
Intel
INTC
|
+$5.32M |
| 4 |
Cabot Corp
CBT
|
+$5.22M |
| 5 |
iShares MSCI EAFE Value ETF
EFV
|
+$4.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.59% |
| 2 | Healthcare | 12.88% |
| 3 | Consumer Discretionary | 9.95% |
| 4 | Financials | 5.61% |
| 5 | Consumer Staples | 5.11% |
Similar funds
DM
GRQ
VA
AV
QC
NW
AAF
PCM
Fiduciary Trust's Q4 2020 Portfolio in Review
As of Q4 2020, Fiduciary Trust held 591 positions worth $4.8B, up 13% from $4.24B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Fiduciary Trust's Q4 2020 filing shows 45 new, 199 increased, 234 reduced and 22 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 33,779 shares worth $2.95M. The largest sale was Moderna, an estimated $83.1M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fiduciary Trust's largest Q4 2020 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 33,779 shares worth $2.95M.
- Fiduciary Trust added most to Microsoft in Q4 2020, an estimated $7.99M increase.
- Fiduciary Trust's biggest Q4 2020 reduction was Moderna, cutting an estimated $83.1M.
- Fiduciary Trust fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $3.09M.
- Fiduciary Trust's ten largest holdings make up 39% of its $4.8B portfolio in Q4 2020.
- Fiduciary Trust opened 45 new positions and closed 22 in Q4 2020.
- Fiduciary Trust's portfolio value rose 13% quarter-over-quarter to $4.8B.
Based on Fiduciary Trust's 13F filing for Q4 2020, filed 26 Jan 2021.